Hims & Hers Stock Plunges on Revenue Miss, Analyst Concerns
Hims & Hers, the telehealth company specialising in wellness and self-care products, has reported a significant drop in orders and a revised, lower revenue forecast for the fourth quarter. The company's stock has taken a hit following a Bank of America analyst report, with investors and analysts expressing concerns about its growth and sustainability.
The report revealed a 16% year-over-year decrease in orders for September. Consequently, the company has lowered its Q4 revenue forecast to $590 million, a substantial drop from the previously expected $632 million. This news comes amidst a strategic leadership restructuring aimed at improving decision-making processes.
Analysts have responded with a mix of recommendations. About 40% suggest holding onto Hims & Hers shares, while 10% advise selling. Some analysts even recommend buying, with price targets around $68. However, the company's recent performance and the increasing competition in the market have raised questions about the sustainability of its growth. The next quarterly report will be crucial in addressing these concerns.
Hims & Hers maintains its annual revenue forecast of $2.3 to $2.4 billion, but the company's recent struggles and the uncertainty expressed by major players in the industry suggest that this target may be challenging to achieve. The company's stock has already taken a hit following a Bank of America analyst report, and investors will be closely watching the next quarterly report to see if Hims & Hers can refute the dark predictions and turn its fortunes around.
Read also:
- Max Planck Scientists Advance Quantum Computers with Less External Control
- Sunrise New Energy Secures Korean Patent for Revolutionary Graphite Anode Tech
- Gold Price Surges to IDR 2,234,000 as Investors Seek Safe Haven
- Amazon Unveils New Kindle Scribe with AI, Color Screen, and More Echo, Fire TV Devices